APO Research
Talk to an analyst

APO RESEARCH · REPORT

Computational Toxicology Solutions

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Computational Toxicology Solutions Market Analysis and Forecast 2026-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchComputational Toxicology Solutions Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Computational Toxicology Solutions Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Computational Toxicology Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Computational Toxicology Solutions Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Computational Toxicology Solutions Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Computational Toxicology Solutions market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Computational Toxicology Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Computational Toxicology Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Computational Toxicology Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Computational Toxicology Solutions is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Computational Toxicology Solutions include Instem (Leadscope), Lhasa Limited, MultiCASE, Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene and Deciphex (Patholytix), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Computational Toxicology Solutions, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Computational Toxicology Solutions, also provides the revenue of main regions and countries. Of the upcoming market potential for Computational Toxicology Solutions, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Computational Toxicology Solutions revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Computational Toxicology Solutions market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Computational Toxicology Solutions revenue, projected growth trends, production technology, application and end-user industry.

Computational Toxicology Solutions Segment by Company

Instem (Leadscope)

Lhasa Limited

MultiCASE

Inotiv

Simulations Plus Inc

Schrodinger

Aclaris

Evogene

Deciphex (Patholytix)

Exscientia

Computational Toxicology Solutions Segment by Type

On-Premise

Cloud-Based

Computational Toxicology Solutions Segment by Application

Academia

Enterprise

Computational Toxicology Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Computational Toxicology Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Computational Toxicology Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Computational Toxicology Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Computational Toxicology Solutions in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Computational Toxicology Solutions company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Computational Toxicology Solutions revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Computational Toxicology Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. On-Premise Major Player Table 3. Cloud-Based Major Player Table 4. Global Computational Toxicology Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Academia Major Player Table 6. Enterprise Major Player Table 7. Computational Toxicology Solutions Industry Trends Table 8. Computational Toxicology Solutions Industry Drivers Table 9. Computational Toxicology Solutions Industry Opportunities and Challenges Table 10. Computational Toxicology Solutions Industry Restraints Table 11. Global Computational Toxicology Solutions Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Computational Toxicology Solutions Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Computational Toxicology Solutions Market Share by Region (2021-2026) Table 14. Global Computational Toxicology Solutions Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Computational Toxicology Solutions Market Share by Region (2027-2032) Table 16. Global Computational Toxicology Solutions Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Computational Toxicology Solutions Revenue Market Share by Players (2021-2026) Table 18. Global Computational Toxicology Solutions Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Computational Toxicology Solutions Key Players Headquarters & Area Served Table 20. Global Computational Toxicology Solutions Players, Product Type & Application Table 21. Global Computational Toxicology Solutions Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Computational Toxicology Solutions by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Computational Toxicology Solutions Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Computational Toxicology Solutions Revenue Market Share by Type (2021-2026) Table 28. Global Computational Toxicology Solutions Revenue Market Share by Type (2027-2032) Table 29. Global Computational Toxicology Solutions Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Computational Toxicology Solutions Revenue Market Share by Application (2021-2026) Table 33. Global Computational Toxicology Solutions Revenue Market Share by Application (2027-2032) Table 34. Instem (Leadscope) Company Information Table 35. Instem (Leadscope) Business Overview Table 36. Instem (Leadscope) Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Instem (Leadscope) Computational Toxicology Solutions Product Portfolio Table 38. Instem (Leadscope) Recent Development Table 39. Lhasa Limited Company Information Table 40. Lhasa Limited Business Overview Table 41. Lhasa Limited Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Lhasa Limited Computational Toxicology Solutions Product Portfolio Table 43. Lhasa Limited Recent Development Table 44. MultiCASE Company Information Table 45. MultiCASE Business Overview Table 46. MultiCASE Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. MultiCASE Computational Toxicology Solutions Product Portfolio Table 48. MultiCASE Recent Development Table 49. Inotiv Company Information Table 50. Inotiv Business Overview Table 51. Inotiv Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Inotiv Computational Toxicology Solutions Product Portfolio Table 53. Inotiv Recent Development Table 54. Simulations Plus Inc Company Information Table 55. Simulations Plus Inc Business Overview Table 56. Simulations Plus Inc Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Simulations Plus Inc Computational Toxicology Solutions Product Portfolio Table 58. Simulations Plus Inc Recent Development Table 59. Schrodinger Company Information Table 60. Schrodinger Business Overview Table 61. Schrodinger Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Schrodinger Computational Toxicology Solutions Product Portfolio Table 63. Schrodinger Recent Development Table 64. Aclaris Company Information Table 65. Aclaris Business Overview Table 66. Aclaris Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Aclaris Computational Toxicology Solutions Product Portfolio Table 68. Aclaris Recent Development Table 69. Evogene Company Information Table 70. Evogene Business Overview Table 71. Evogene Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Evogene Computational Toxicology Solutions Product Portfolio Table 73. Evogene Recent Development Table 74. Deciphex (Patholytix) Company Information Table 75. Deciphex (Patholytix) Business Overview Table 76. Deciphex (Patholytix) Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio Table 78. Deciphex (Patholytix) Recent Development Table 79. Exscientia Company Information Table 80. Exscientia Business Overview Table 81. Exscientia Computational Toxicology Solutions Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Exscientia Computational Toxicology Solutions Product Portfolio Table 83. Exscientia Recent Development Table 84. North America Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 85. North America Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 86. North America Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 87. North America Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 88. North America Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Computational Toxicology Solutions Revenue by Country (2021-2026) & (US$ Million) Table 90. North America Computational Toxicology Solutions Revenue by Country (US$ Million) & (2027-2032) Table 91. Europe Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 94. Europe Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 95. Europe Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Europe Computational Toxicology Solutions Revenue by Country (2021-2026) & (US$ Million) Table 97. Europe Computational Toxicology Solutions Revenue by Country (US$ Million) & (2027-2032) Table 98. China Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 99. China Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 100. China Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 101. China Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 102. Asia Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 103. Asia Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 104. Asia Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 105. Asia Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Computational Toxicology Solutions Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 107. Asia Computational Toxicology Solutions Revenue by Region (US$ Million) & (2021-2026) Table 108. Asia Computational Toxicology Solutions Revenue by Region (US$ Million) & (2027-2032) Table 109. SAMEA Computational Toxicology Solutions Revenue by Type (2021-2026) & (US$ Million) Table 110. SAMEA Computational Toxicology Solutions Revenue by Type (2027-2032) & (US$ Million) Table 111. SAMEA Computational Toxicology Solutions Revenue by Application (2021-2026) & (US$ Million) Table 112. SAMEA Computational Toxicology Solutions Revenue by Application (2027-2032) & (US$ Million) Table 113. SAMEA Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. SAMEA Computational Toxicology Solutions Revenue by Country (2021-2026) & (US$ Million) Table 115. SAMEA Computational Toxicology Solutions Revenue by Country (US$ Million) & (2027-2032) Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Computational Toxicology Solutions Image Figure 2. Global Computational Toxicology Solutions Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Computational Toxicology Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 4. On-Premise Image Figure 5. Cloud-Based Image Figure 6. Global Computational Toxicology Solutions Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Computational Toxicology Solutions Market Size Share 2021 VS 2025 VS 2032 Figure 8. Academia Image Figure 9. Enterprise Image Figure 10. Global Computational Toxicology Solutions Market Size (US$ Million) & (2021-2032) Figure 11. Global Computational Toxicology Solutions Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Computational Toxicology Solutions Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Computational Toxicology Solutions Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Computational Toxicology Solutions Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Computational Toxicology Solutions Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Computational Toxicology Solutions Revenue Market Share by Type (2021-2032) Figure 18. Global Computational Toxicology Solutions Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Computational Toxicology Solutions Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Computational Toxicology Solutions Revenue Market Share by Application (2021-2032) Figure 21. North America Computational Toxicology Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Computational Toxicology Solutions Revenue Share by Type (2021-2032) Figure 23. North America Computational Toxicology Solutions Revenue Share by Application (2021-2032) Figure 24. North America Computational Toxicology Solutions Revenue Share by Country (2021-2032) Figure 25. United States Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Computational Toxicology Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Computational Toxicology Solutions Revenue Share by Type (2021-2032) Figure 30. Europe Computational Toxicology Solutions Revenue Share by Application (2021-2032) Figure 31. Europe Computational Toxicology Solutions Revenue Share by Country (2021-2032) Figure 32. Germany Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Computational Toxicology Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Computational Toxicology Solutions Revenue Share by Type (2021-2032) Figure 42. China Computational Toxicology Solutions Revenue Share by Application (2021-2032) Figure 43. Asia Computational Toxicology Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Computational Toxicology Solutions Revenue Share by Type (2021-2032) Figure 45. Asia Computational Toxicology Solutions Revenue Share by Application (2021-2032) Figure 46. Asia Computational Toxicology Solutions Revenue Share by Region (2021-2032) Figure 47. Japan Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Computational Toxicology Solutions Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Computational Toxicology Solutions Revenue Share by Type (2021-2032) Figure 55. SAMEA Computational Toxicology Solutions Revenue Share by Application (2021-2032) Figure 56. SAMEA Computational Toxicology Solutions Revenue Share by Country (2021-2032) Figure 57. Brazil Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Computational Toxicology Solutions Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • On-Premise
  • Cloud-Based
Applications
  • Academia
  • Enterprise
Companies covered
  • Instem (Leadscope)
  • Lhasa Limited
  • MultiCASE
  • Inotiv
  • Simulations Plus Inc
  • Schrodinger
  • Aclaris
  • Evogene
  • Deciphex (Patholytix)
  • Exscientia

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Computational Toxicology Solutions Market by Type
  3. 1.2.1 Global Computational Toxicology Solutions Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 On-Premise
  5. 1.2.3 Cloud-Based
  6. 1.3 Computational Toxicology Solutions Market by Application
  7. 1.3.1 Global Computational Toxicology Solutions Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Academia
  9. 1.3.3 Enterprise
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Computational Toxicology Solutions Market Dynamics
  1. 2.1 Computational Toxicology Solutions Industry Trends
  2. 2.2 Computational Toxicology Solutions Industry Drivers
  3. 2.3 Computational Toxicology Solutions Industry Opportunities and Challenges
  4. 2.4 Computational Toxicology Solutions Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Computational Toxicology Solutions Market Perspective (2021-2032)
  2. 3.2 Global Computational Toxicology Solutions Growth Trends by Region
  3. 3.2.1 Global Computational Toxicology Solutions Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Computational Toxicology Solutions Market Size by Region (2021-2026)
  5. 3.2.3 Global Computational Toxicology Solutions Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Computational Toxicology Solutions Revenue by Players
  2. 4.1.1 Global Computational Toxicology Solutions Revenue by Players (2021-2026)
  3. 4.1.2 Global Computational Toxicology Solutions Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Computational Toxicology Solutions Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Computational Toxicology Solutions Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Computational Toxicology Solutions Key Players Headquarters & Area Served
  7. 4.4 Global Computational Toxicology Solutions Players, Product Type & Application
  8. 4.5 Global Computational Toxicology Solutions Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Computational Toxicology Solutions Market CR5 and HHI
  11. 4.6.3 2025 Computational Toxicology Solutions Tier 1, Tier 2, and Tier 3
5 Computational Toxicology Solutions Market Size by Type
  1. 5.1 Global Computational Toxicology Solutions Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 5.3 Global Computational Toxicology Solutions Revenue Market Share by Type (2021-2032)
6 Computational Toxicology Solutions Market Size by Application
  1. 6.1 Global Computational Toxicology Solutions Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Computational Toxicology Solutions Revenue by Application (2021-2032)
  3. 6.3 Global Computational Toxicology Solutions Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Instem (Leadscope)
  2. 7.1.1 Instem (Leadscope) Company Information
  3. 7.1.2 Instem (Leadscope) Business Overview
  4. 7.1.3 Instem (Leadscope) Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Instem (Leadscope) Computational Toxicology Solutions Product Portfolio
  6. 7.1.5 Instem (Leadscope) Recent Developments
  7. 7.2 Lhasa Limited
  8. 7.2.1 Lhasa Limited Company Information
  9. 7.2.2 Lhasa Limited Business Overview
  10. 7.2.3 Lhasa Limited Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lhasa Limited Computational Toxicology Solutions Product Portfolio
  12. 7.2.5 Lhasa Limited Recent Developments
  13. 7.3 MultiCASE
  14. 7.3.1 MultiCASE Company Information
  15. 7.3.2 MultiCASE Business Overview
  16. 7.3.3 MultiCASE Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  17. 7.3.4 MultiCASE Computational Toxicology Solutions Product Portfolio
  18. 7.3.5 MultiCASE Recent Developments
  19. 7.4 Inotiv
  20. 7.4.1 Inotiv Company Information
  21. 7.4.2 Inotiv Business Overview
  22. 7.4.3 Inotiv Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Inotiv Computational Toxicology Solutions Product Portfolio
  24. 7.4.5 Inotiv Recent Developments
  25. 7.5 Simulations Plus Inc
  26. 7.5.1 Simulations Plus Inc Company Information
  27. 7.5.2 Simulations Plus Inc Business Overview
  28. 7.5.3 Simulations Plus Inc Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Simulations Plus Inc Computational Toxicology Solutions Product Portfolio
  30. 7.5.5 Simulations Plus Inc Recent Developments
  31. 7.6 Schrodinger
  32. 7.6.1 Schrodinger Company Information
  33. 7.6.2 Schrodinger Business Overview
  34. 7.6.3 Schrodinger Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Schrodinger Computational Toxicology Solutions Product Portfolio
  36. 7.6.5 Schrodinger Recent Developments
  37. 7.7 Aclaris
  38. 7.7.1 Aclaris Company Information
  39. 7.7.2 Aclaris Business Overview
  40. 7.7.3 Aclaris Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aclaris Computational Toxicology Solutions Product Portfolio
  42. 7.7.5 Aclaris Recent Developments
  43. 7.8 Evogene
  44. 7.8.1 Evogene Company Information
  45. 7.8.2 Evogene Business Overview
  46. 7.8.3 Evogene Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Evogene Computational Toxicology Solutions Product Portfolio
  48. 7.8.5 Evogene Recent Developments
  49. 7.9 Deciphex (Patholytix)
  50. 7.9.1 Deciphex (Patholytix) Company Information
  51. 7.9.2 Deciphex (Patholytix) Business Overview
  52. 7.9.3 Deciphex (Patholytix) Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Deciphex (Patholytix) Computational Toxicology Solutions Product Portfolio
  54. 7.9.5 Deciphex (Patholytix) Recent Developments
  55. 7.10 Exscientia
  56. 7.10.1 Exscientia Company Information
  57. 7.10.2 Exscientia Business Overview
  58. 7.10.3 Exscientia Computational Toxicology Solutions Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Exscientia Computational Toxicology Solutions Product Portfolio
  60. 7.10.5 Exscientia Recent Developments
8 North America
  1. 8.1 North America Computational Toxicology Solutions Revenue (2021-2032)
  2. 8.2 North America Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 8.2.1 North America Computational Toxicology Solutions Revenue by Type (2021-2026)
  4. 8.2.2 North America Computational Toxicology Solutions Revenue by Type (2027-2032)
  5. 8.3 North America Computational Toxicology Solutions Revenue Share by Type (2021-2032)
  6. 8.4 North America Computational Toxicology Solutions Revenue by Application (2021-2032)
  7. 8.4.1 North America Computational Toxicology Solutions Revenue by Application (2021-2026)
  8. 8.4.2 North America Computational Toxicology Solutions Revenue by Application (2027-2032)
  9. 8.5 North America Computational Toxicology Solutions Revenue Share by Application (2021-2032)
  10. 8.6 North America Computational Toxicology Solutions Revenue by Country
  11. 8.6.1 North America Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Computational Toxicology Solutions Revenue by Country (2021-2026)
  13. 8.6.3 North America Computational Toxicology Solutions Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Computational Toxicology Solutions Revenue (2021-2032)
  2. 9.2 Europe Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 9.2.1 Europe Computational Toxicology Solutions Revenue by Type (2021-2026)
  4. 9.2.2 Europe Computational Toxicology Solutions Revenue by Type (2027-2032)
  5. 9.3 Europe Computational Toxicology Solutions Revenue Share by Type (2021-2032)
  6. 9.4 Europe Computational Toxicology Solutions Revenue by Application (2021-2032)
  7. 9.4.1 Europe Computational Toxicology Solutions Revenue by Application (2021-2026)
  8. 9.4.2 Europe Computational Toxicology Solutions Revenue by Application (2027-2032)
  9. 9.5 Europe Computational Toxicology Solutions Revenue Share by Application (2021-2032)
  10. 9.6 Europe Computational Toxicology Solutions Revenue by Country
  11. 9.6.1 Europe Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Computational Toxicology Solutions Revenue by Country (2021-2026)
  13. 9.6.3 Europe Computational Toxicology Solutions Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Computational Toxicology Solutions Revenue (2021-2032)
  2. 10.2 China Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 10.2.1 China Computational Toxicology Solutions Revenue by Type (2021-2026)
  4. 10.2.2 China Computational Toxicology Solutions Revenue by Type (2027-2032)
  5. 10.3 China Computational Toxicology Solutions Revenue Share by Type (2021-2032)
  6. 10.4 China Computational Toxicology Solutions Revenue by Application (2021-2032)
  7. 10.4.1 China Computational Toxicology Solutions Revenue by Application (2021-2026)
  8. 10.4.2 China Computational Toxicology Solutions Revenue by Application (2027-2032)
  9. 10.5 China Computational Toxicology Solutions Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Computational Toxicology Solutions Revenue (2021-2032)
  2. 11.2 Asia Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 11.2.1 Asia Computational Toxicology Solutions Revenue by Type (2021-2026)
  4. 11.2.2 Asia Computational Toxicology Solutions Revenue by Type (2027-2032)
  5. 11.3 Asia Computational Toxicology Solutions Revenue Share by Type (2021-2032)
  6. 11.4 Asia Computational Toxicology Solutions Revenue by Application (2021-2032)
  7. 11.4.1 Asia Computational Toxicology Solutions Revenue by Application (2021-2026)
  8. 11.4.2 Asia Computational Toxicology Solutions Revenue by Application (2027-2032)
  9. 11.5 Asia Computational Toxicology Solutions Revenue Share by Application (2021-2032)
  10. 11.6 Asia Computational Toxicology Solutions Revenue by Country
  11. 11.6.1 Asia Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Computational Toxicology Solutions Revenue by Country (2021-2026)
  13. 11.6.3 Asia Computational Toxicology Solutions Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Computational Toxicology Solutions Revenue (2021-2032)
  2. 12.2 SAMEA Computational Toxicology Solutions Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Computational Toxicology Solutions Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Computational Toxicology Solutions Revenue by Type (2027-2032)
  5. 12.3 SAMEA Computational Toxicology Solutions Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Computational Toxicology Solutions Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Computational Toxicology Solutions Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Computational Toxicology Solutions Revenue by Application (2027-2032)
  9. 12.5 SAMEA Computational Toxicology Solutions Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Computational Toxicology Solutions Revenue by Country
  11. 12.6.1 SAMEA Computational Toxicology Solutions Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Computational Toxicology Solutions Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Computational Toxicology Solutions Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst